Managing Litigation Risks in De-SPAC Transactions 

As SPAC litigation continues to proliferate, it is more important than ever that officers and directors of companies undertaking a de-SPAC transaction be mindful of litigation risks and adopt strategies for managing them. After all, a de-SPAC transaction—by definition—thrusts a formerly private enterprise into the more litigious world of publicly traded companies.

Vinson & Elkins will conduct a webinar on this topic Oct. 26 from 1-2 ET.

The presentation will survey the different types of securities and M&A litigation arising from de-SPAC transactions—including Delaware fiduciary duty litigation, federal securities class actions, derivative lawsuits, SEC investigations, and de-SPAC counterparty litigation. It will also address the circumstances and factual allegations commonly giving rise to these types of litigation, with a particular focus on proxy disclosures and short seller reports. Register here.

Total
0
Shares
Related Posts
Read More

ICR’s SPAC Market Update Shows Normalization

The SPAC IPO market seems to have normalized, with six SPAC IPOs pricing during the first quarter, of which over 30% were from serial sponsors that returned to the market. These serial sponsors elected to raise larger trusts, increasing average SPAC IPO size for Q1 to $114 million, up 2% from Q4 2023 and 39% from the same quarter last year.